Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 58

Cited In for PubMed (Select 7909009)

1.

Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration.

Ekouévi DK, Avettand-Fènoël V, Tchounga BK, Coffie PA, Sawadogo A, Minta D, Minga A, Eholie SP, Plantier JC, Damond F, Dabis F, Rouzioux C; IeDEA West Africa collaboration.

PLoS One. 2015 Jun 25;10(6):e0129886. doi: 10.1371/journal.pone.0129886. eCollection 2015.

2.

Thymic HIV-2 infection uncovers posttranscriptional control of viral replication in human thymocytes.

Nunes-Cabaço H, Matoso P, Foxall RB, Tendeiro R, Pires AR, Carvalho T, Pinheiro AI, Soares RS, Sousa AE.

J Virol. 2015 Feb;89(4):2201-8. doi: 10.1128/JVI.03047-14. Epub 2014 Dec 3.

3.

New sensitive one-step real-time duplex PCR method for group A and B HIV-2 RNA load.

Avettand-Fenoel V, Damond F, Gueudin M, Matheron S, Mélard A, Collin G, Descamps D, Chaix ML, Rouzioux C, Plantier JC; ANRS-CO5 HIV-2 and the ANRS-AC11 Quantification Working Group.

J Clin Microbiol. 2014 Aug;52(8):3017-22. doi: 10.1128/JCM.00724-14. Epub 2014 Jun 11.

4.

Genotypic resistance profiles of HIV-2-treated patients in West Africa.

Charpentier C, Eholié S, Anglaret X, Bertine M, Rouzioux C, Avettand-Fenoël V, Messou E, Minga A, Damond F, Plantier JC, Dabis F, Peytavin G, Brun-Vézinet F, Ekouevi DK; IeDEA West Africa Collaboration.

AIDS. 2014 May 15;28(8):1161-9. doi: 10.1097/QAD.0000000000000244.

5.

Viral factors in non-progression.

Wang B.

Front Immunol. 2013 Dec 24;4:355. doi: 10.3389/fimmu.2013.00355. Review.

6.

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa.

Amornkul PN, Karita E, Kamali A, Rida WN, Sanders EJ, Lakhi S, Price MA, Kilembe W, Cormier E, Anzala O, Latka MH, Bekker LG, Allen SA, Gilmour J, Fast PE; IAVI Africa HIV Prevention Partnership.

AIDS. 2013 Nov 13;27(17):2775-86. doi: 10.1097/QAD.0000000000000012.

7.

Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study.

Ekouevi DK, Balestre E, Coffie PA, Minta D, Messou E, Sawadogo A, Minga A, Sow PS, Bissagnene E, Eholie SP, Gottlieb GS, Dabis F; IeDEA West Africa collaboration, Zannou DM, Ahouada C, Akakpo J, Ahomadegbé C, Bashi J, Gougounon-Houéto A, Azon-Kouanou A, Houngbé F, Koumakpaï S, Alihonou F, d'Almeida M, Hodonou I, Hounhoui G, Sagbo G, Tossa-Bagnan L, Adjide H, Drabo J, Bognounou R, Dienderé A, Traore E, Zoungrana L, Zerbo B, Sawadogo AB, Zoungrana J, Héma A, Soré I, Bado G, Tapsoba A, Yé D, Kouéta F, Ouedraogo S, Ouédraogo R, Hiembo W, Gansonré M, Messou E, Gnokoro JC, Koné M, Kouakou GM, Bosse CA, Brou K, Assi AI, Chenal H, Hawerlander D, Soppi F, Minga A, Abo Y, Bomisso G, Eholié SP, Amego MD, Andavi V, Diallo Z, Ello F, Tanon AK, Koule SO, Anzan KC, Guehi C, Aka EA, Issouf KL, Kouakou JC, N'gbeche MS, Touré P, Avit-Edi D, Kouakou K, Moh M, Yao VA, Folquet MA, Dainguy ME, Kouakou C, Méa-Assande VT, Oka-Berete G, Zobo N, Acquah P, Kokora MB, Eboua TF, Timité-Konan M, Ahoussou LD, Assouan JK, Sami MF, Kouadio C, Renner L, Goka B, Welbeck J, Sackey A, Owiafe SN, Wejse C, Silva ZJ, Paulo J, Rodrigues A, da Silva D, Medina C, Oliviera-Souto I, Ostergaard L, Laursen A, Sodemann M, Aaby P, Fomsgaard A, Erikstrup C, Eugen-Olsen J, Maïga MY, Diakité FF, Kalle A, Katile D, Traore HA, Minta D, Cissé T, Dembelé M, Doumbia M, Fomba M, Kaya AS, Traoré AM, Traoré H, Toure AA, Dicko F, Sylla M, Berthé A, Traoré HC, Koïta A, Koné N, N'diaye C, Coulibaly ST, Traoré M, Traoré N, Charurat M, Ajayi S, Dapiap S, Otu, Igbinoba F, Benson O, Adebamowo C, James J, Obaseki, Osakede P, Olasode J, Sow PS, Diop B, Manga NM, Tine JM, Signate Sy H, Ba A, Diagne A, Dior H, Faye M, Gueye RD, Mbaye AD, Patassi A, Kotosso A, Kariyare BG, Gbadamassi G, Komi A, Mensah-Zukong KE, Pakpame P, Lawson-Evi AK, Atakouma Y, Takassi E, Djeha A, Ephoévi-Gah A, Djibril SE, Dabis F, Bissagnene E, Arrivé E, Coffie P, Ekouevi D, Jaquet A, Leroy V, Lewden C, Sasco A, Azani JC, Allou G, Balestre E, Bohossou F, Karcher S, Gonsan JM, Carrou JL, Lenaud S, Nchot C, Malateste K, Yao AR, Siloué B, Clouet G, Djetouan H, Doring A, Kouakou A, Rabourdin E, Rivenc J, Anglaret X, Ba B, Essanin JB, Ciaranello A, Datté S, Desmonde S, Diby JS, Gottlieb GS, Horo AG, Kangah SN, Malvy D, Meless D, Mounkaila-Harouna A, Ndondoki C, Shiboski C, Thiébaut R, Pac-Ci, Abidjan.

PLoS One. 2013 Jun 18;8(6):e66135. Print 2013.

8.

HIV-1 outcompetes HIV-2 in dually infected Senegalese individuals with low CD4⁺ cell counts.

Raugi DN, Gottlieb GS, Sow PS, Toure M, Sall F, Gaye A, N'doye I, Kiviat NB, Hawes SE; University of Washington-Dakar HIV Study Group.

AIDS. 2013 Sep 24;27(15):2441-50. doi: 10.1097/QAD.0b013e328362e856.

9.

Changing HIV epidemics: what HIV-2 can teach us about ending HIV-1.

Gottlieb GS.

AIDS. 2013 Jan 2;27(1):135-7. doi: 10.1097/QAD.0b013e32835a11a4. No abstract available.

10.

Trends of HIV-1, HIV-2 and dual infection in women attending outpatient clinics in Senegal, 1990-2009.

Heitzinger K, Sow PS, Dia Badiane NM, Gottlieb GS, N'Doye I, Toure M, Kiviat NB, Hawes SE; University of Washington-Dakar HIV and Cervical Cancer Study Group.

Int J STD AIDS. 2012 Oct;23(10):710-6. doi: 10.1258/ijsa.2012.011219.

11.

Frequent intratype neutralization by plasma immunoglobulin a identified in HIV type 2 infection.

Özkaya Şahin G, Månsson F, Palm AA, Vincic E, da Silva Z, Medstrand P, Norrgren H, Fenyö EM, Jansson M.

AIDS Res Hum Retroviruses. 2013 Mar;29(3):470-8. doi: 10.1089/AID.2012.0219. Epub 2012 Nov 21.

12.

Validation for clinical use of a novel HIV-2 plasma RNA viral load assay using the Abbott m2000 platform.

Chang M, Gottlieb GS, Dragavon JA, Cherne SL, Kenney DL, Hawes SE, Smith RA, Kiviat NB, Sow PS, Coombs RW.

J Clin Virol. 2012 Oct;55(2):128-33. doi: 10.1016/j.jcv.2012.06.024. Epub 2012 Jul 24.

13.

Natural simian immunodeficiency virus transmission in mandrills: a family affair?

Fouchet D, Verrier D, Ngoubangoye B, Souquière S, Makuwa M, Kazanji M, Gonzalez JP, Pontier D.

Proc Biol Sci. 2012 Sep 7;279(1742):3426-35. doi: 10.1098/rspb.2012.0963. Epub 2012 Jun 6.

14.

HIV-2 integrase variation in integrase inhibitor-naïve adults in Senegal, West Africa.

Gottlieb GS, Smith RA, Dia Badiane NM, Ba S, Hawes SE, Toure M, Starling AK, Traore F, Sall F, Cherne SL, Stern J, Wong KG, Lu P, Kim M, Raugi DN, Lam A, Mullins JI, Kiviat NB; Papa Salif Sow for the UW-Dakar HIV-2 Study Group.

PLoS One. 2011;6(7):e22204. doi: 10.1371/journal.pone.0022204. Epub 2011 Jul 12.

15.

Update on human immunodeficiency virus (HIV)-2 infection.

Campbell-Yesufu OT, Gandhi RT.

Clin Infect Dis. 2011 Mar 15;52(6):780-7. doi: 10.1093/cid/ciq248. Review.

16.

Human immunodeficiency virus type 2 in two Saudi families.

Almaghrabi RS, Ali B, Al-Thawadi S, Halim MA, Alrajhi AA.

Ann Saudi Med. 2011 Jul-Aug;31(4):417-20. doi: 10.4103/0256-4947.76408.

17.

Characteristics, immunological response & treatment outcomes of HIV-2 compared with HIV-1 & dual infections (HIV 1/2) in Mumbai.

Chiara M, Rony Z, Homa M, Bhanumati V, Ladomirska J, Manzi M, Wilson N, Alaka D, Harries AD.

Indian J Med Res. 2010 Dec;132:683-9.

18.

Cell-associated viral burden provides evidence of ongoing viral replication in aviremic HIV-2-infected patients.

Soares RS, Tendeiro R, Foxall RB, Baptista AP, Cavaleiro R, Gomes P, Camacho R, Valadas E, Doroana M, Lucas M, Antunes F, Victorino RM, Sousa AE.

J Virol. 2011 Mar;85(5):2429-38. doi: 10.1128/JVI.01921-10. Epub 2010 Dec 15.

19.

Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.

Jallow S, Alabi A, Sarge-Njie R, Peterson K, Whittle H, Corrah T, Jaye A, Cotten M, Vanham G, McConkey SJ, Rowland-Jones S, Janssens W.

J Clin Microbiol. 2009 Jul;47(7):2200-8. doi: 10.1128/JCM.01654-08. Epub 2009 May 6.

20.

Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa.

Gottlieb GS, Badiane NM, Hawes SE, Fortes L, Toure M, Ndour CT, Starling AK, Traore F, Sall F, Wong KG, Cherne SL, Anderson DJ, Dye SA, Smith RA, Mullins JI, Kiviat NB, Sow PS; University of Washington-Dakar HIV-2 Study Group.

Clin Infect Dis. 2009 Feb 15;48(4):476-83. doi: 10.1086/596504. Erratum in: Clin Infect Dis. 2009 Mar 15;48(6):848.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk